Why is DocGo, Inc. ?
- The company has declared negative results for the last 2 consecutive quarters
- INTEREST(9M) At USD 1.41 MM has Grown at 59.9%
- ROCE(HY) Lowest at -5.98%
- NET SALES(Q) Lowest at USD 80.42 MM
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -79.54%, its profits have fallen by -140.2%
- Along with generating -79.54% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is DocGo, Inc. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 87.18 MM
At USD 1.41 MM has Grown at 59.9%
Lowest at -5.98%
Lowest at USD 80.42 MM
Lowest at USD -13.5 MM
Lowest at USD -17.91 MM
Lowest at USD -11.15 MM
Grown by 15.4% (YoY
Lowest at 2.29 times
Lowest at -16.79 %
Lowest at USD -0.11
Here's what is working for DocGo, Inc.
Operating Cash Flows (USD MM)
Here's what is not working for DocGo, Inc.
Net Sales (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Interest Paid (USD MM)
Net Sales (USD MM)
Operating Profit (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Operating Profit to Sales
EPS (USD)
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales






